Sexually transmitted diseases and HIV co-infection among adult male patients in the 2022 monkeypox outbreak: a systematic review and meta-analysis


Published: 6 February 2024
Abstract Views: 93
PDF: 83
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Aim. This meta-analysis estimates the prevalence of sexually transmitted diseases (STIs) and HIV infection among male patients diagnosed with Monkeypox during the 2022 outbreak. The study also explores contextual factors associated with higher risk of monkeypox infection. Methods. A systematic review of literature was initially conducted through PubMed/ Medline, Scopus, and Google Scholar to retrieve observational studies describing demographics and medical characteristics of Monkeypox patients affected in the 2022 outbreak. The System for the Unified Management, Assessment, and Review of Information -Joanna Briggs Institute (SUMARI JBI) guidelines was used to conduct the meta-analysis of this review. All data relevant to prevalence of HIV and STIs in male patients diagnosed with Monkeypox were extracted and exported into the JBI SUMARI. To assess point prevalence of HIV and STIs, we used the Freeman-Tukey-type arcsine square root transformation to stabilize the variances of the raw proportions. All estimates were weighted and pooled by the inverse variance using a fixed-effects model. We then used a random model to account for sampling variation and reported heterogeneity in effect size noted across studies in the fixed-effect model. The I2 test statistic and P values were used to measure the heterogeneity between studies. Values of I2 test statistic results were interpreted as follows: low (25%), moderate (50%) and high (75%). Results. Six studies from Spain and the UK met the inclusion criteria. These studies described a total of 541 male patients with monkeypox, 214 of them were positive for HIV and 255 had other STIs. Overall estimated prevalence of HIV and STIs was 40% (95% CI = 0.31%, 0.50%; ᵡ2 = 15) and 43% (95% CI = 25%, 61%; ᵡ2 = 118), respectively. Outcomes indicated moderate to high heterogeneity in the overall analyses. Conclusions. Approximately four in ten male patients affected in the 2022 Monkeypox outbreak had HIV and/or other STIs. Necessary public health measures should target male and female patients who are at risk of Monkeypox infection to prevent the transmission of serious infections such as HIV and other STIs.


Elsayed S, Abu-Hammad O, Alolayan A, Althagafi N, Ayed Y, Salah Eldeen Y, Dar-Odeh N. Getting to Know SARS-cov-2: Towards a Better Understanding of the Factors Influencing Transmission. Pesquisa Brasileira em Odontopediatria e Clínica Integrada 2020; 20(supp1):e0122. DOI: https://doi.org/10.1590/pboci.2020.123

Abu-Hammad O, Abu-Hammad A, Jaber AR, Jaber AR, Dar-Odeh N. Factors associated with geographic variations in the 2022 monkeypox outbreak; A systematic review. New Microbes New Infect. 2023 Jan;51:101078. DOI: https://doi.org/10.1016/j.nmni.2022.101078

Mathieu E, Spooner F, Dattani S, Ritchie H, Roser M. (2022) - "Mpox (monkeypox)". Published online at OurWorldInData.org. Retrieved from: 'https://ourworldindata.org/monkeypox' https://ourworldindata.org/monkeypox, accessed 11 September 2023.

Benites-Zapata VA, Ulloque-Badaracco JR, Alarcon-Braga EA, et al. Clinical features, hospitalisation and deaths associated with monkeypox: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob. 2022;21(1):36. DOI: https://doi.org/10.1186/s12941-022-00527-1

Hasan, S.; Saeed, S. Monkeypox Disease: An Emerging Public Health Concern in the Shadow of COVID-19 Pandemic: An Update. Trop. Med. Infect. Dis. 2022, 7, 283. DOI: https://doi.org/10.3390/tropicalmed7100283

2022 Mpox Outbreak Global Map. https://www.cdc.gov/poxvirus/mpox/response/2022/world-map.html. Accessed 11. September 2023.

Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y. Prevention and treatment of monkeypox. Drugs 2022;82:957–63. DOI: https://doi.org/10.1007/s40265-022-01742-y

Bragazzi NL, Kong JD, Wu J. Is monkeypox a new, emerging sexually transmitted disease? A rapid review of the literature. J Med Virol. 2023 Jan;95(1):e28145. DOI: https://doi.org/10.1002/jmv.28145

Grothe JH, Cornely OA, Salmanton-García J; VACCELERATE consortium. Monkeypox in children and adult women in Europe: Results from a flash VACCELERATE pilot survey. Enferm Infecc Microbiol Clin. 2022 Sep 19. DOI: https://doi.org/10.1016/j.eimc.2022.08.002

Ortiz-Martínez Y, Zambrano-Sanchez G, Rodríguez-Morales AJ. Monkeypox and HIV/AIDS: When the outbreak faces the epidemic. Int J STD AIDS. 2022 Sep;33(10):949-950. DOI: https://doi.org/10.1177/09564624221114191

Ribeiro S, de Sousa D, Medina D, Castro R, Lopes Â, Rocha M. Prevalence of gonorrhea and chlamydia in a community clinic for men who have sex with men in Lisbon, Portugal. Int J STD AIDS. 2019 Sep;30(10):951-959. DOI: https://doi.org/10.1177/0956462419855484

2022-23 Mpox (Monkeypox) Outbreak:Global Trends. https://worldhealthorg.shinyapps.io/mpx_global/, accessed 23/5/2023.

Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evidence Synthesis 2020;18:2127–33. DOI: https://doi.org/10.11124/JBISRIR-D-19-00099

Moola SMZ, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K, Mu P-F. JBI manual for evidence synthesis. JBI; 2020.

JBI SUMARI. n.d., Joanna Briggs Institute, Adelaide, South Australia.

Catala A, Clavo-Escribano P, Riera-Monroig J, Martin-Ezquerra G, Fernandez-Gonzalez P, Revelles-Penas L, et al. Monkeypox outbreak in Spain: clinical and epidemiological findings in a prospective cross sectionalstudy of 185 cases. The British Journal of Dermatology 2022;187(5):765–72. DOI: https://doi.org/10.1111/bjd.21790

Orviz E, Negredo A, Ayerdi O, Vazquez A, Munoz-Gomez A, Monzon S, et al. Monkeypox outbreak in Madrid [Spain]: clinical and virological aspects. The Journal of Infection 2022;85:412–7. DOI: https://doi.org/10.1016/j.jinf.2022.07.005

Gomez-Garberi M, Sarrio-Sanz P, Martinez-Cayuelas L, Delgado-Sanchez E, Bernabeu-Cabezas S, Peris-Garcia J, et al. Genitourinary lesions due to monkeypox. European urology; 2022. DOI: https://doi.org/10.1016/j.eururo.2022.08.034

Patel A, Bilinska J, Tam JCH, Da Silva Fontoura D, Mason CY, Daunt A, et al. Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series. Bmj 2022;378:e072410. DOI: https://doi.org/10.1136/bmj-2022-072410

Girometti N, Byrne R, Bracchi M, Heskin J, McOwan A, Tittle V, et al. Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis. The Lancet Infectious Diseases 2022;22:1321–8. DOI: https://doi.org/10.1016/S1473-3099(22)00411-X

Vusirikala A, Charles H, Balasegaram S, Macdonald N, Kumar D, Barker-Burnside C, et al. Epidemiology of early monkeypox virus transmission in sexual networks of gay and bisexual men, England, 2022. Emerging Infectious Diseases 2022;28:2082–6. DOI: https://doi.org/10.3201/eid2810.220960

Multi-country outbreak of mpox, External situation report #27 - 14 August 2023. https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report-27---14-august-2023. accessed 9/11/2023.

Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis. 2022 Feb 11;16(2):e0010141. DOI: https://doi.org/10.1371/journal.pntd.0010141

Abed Alah M, Abdeen S, Tayar E, Bougmiza I. The story behind the first few cases of monkeypox infection in non-endemic countries, 2022. Journal of Infection and Public Health 2022;15:970–4. DOI: https://doi.org/10.1016/j.jiph.2022.07.014

Hoffmann C, Jessen H, Boesecke C. Monkeypox in Germany. Dtsch Arztebl Int. 2022 Aug 22;119(33-34):551-557.

Curran KG, Eberly K, Russell OO, Snyder RE, Phillips EK, Tang EC, Peters PJ, Sanchez MA, Hsu L, Cohen SE, Sey EK, Yin S, Foo C, Still W, Mangla A, Saafir-Callaway B, Barrineau-Vejjajiva L, Meza C, Burkhardt E, Smith ME, Murphy PA, Kelly NK, Spencer H, Tabidze I, Pacilli M, Swain CA, Bogucki K, DelBarba C, Rajulu DT, Dailey A, Ricaldi J, Mena LA, Daskalakis D, Bachmann LH, Brooks JT, Oster AM; Monkeypox, HIV, and STI Team. HIV and Sexually Transmitted Infections Among Persons with Monkeypox - Eight U.S. Jurisdictions, May 17-July 22, 2022. MMWR Morb Mortal Wkly Rep. 2022 Sep 9;71(36):1141-1147. DOI: https://doi.org/10.15585/mmwr.mm7136a1

Tingley K. After reaching historic lows more than a decade ago, rates of some sexually transmitted infections are on the rise again. Why? New York Times Sunday Magazine, May22, 2022, pp. 12–14

Newman DR, Matthias J, Rahman MMK, et al. Repeat syphilis among HIV-infected men in Florida and Louisiana2000–2018: Implications for screening recommendations.AIDS Patient Care STDs 2021;35(11):435–440). DOI: https://doi.org/10.1089/apc.2021.0081

Schnohr CCS, Paulsen FW, Larsen L, et al. Neurosyphilis among people with and without HIV infection: A Danish nationwide prospective, population-based cohort study 2015-2021. J Infect. 2023;86(5):439-445 DOI: https://doi.org/10.1016/j.jinf.2023.03.019

Laurence J. The Recent Rise in Sexually Transmitted Infections in the United States Was a Harbinger of the New Monkeypox Pandemic. AIDS Patient Care STDS. 2022 Sep;36(9):333-335. DOI: https://doi.org/10.1089/apc.2022.29009.com

The CDC Reports an Alarming Surge in Congenital Syphilis. Am J Nurs. 2023;123(7):11.) DOI: https://doi.org/10.1097/01.NAJ.0000944860.06843.d5

Blouin K, Lefebvre B, Trudelle A, et al. Correlates of Neisseria gonorrhoeae antimicrobial resistance: cross-sectional results from an open cohort sentinel surveillance network in Québec, Canada, 2016-2019. BMJ Open. 2023;13(8):e073849. DOI: https://doi.org/10.1136/bmjopen-2023-073849

Ortiz-Saavedra B, Montes-Madariaga ES, Cabanillas-Ramirez C, et al. Epidemiologic Situation of HIV and Monkeypox Coinfection: A Systematic Review. Vaccines (Basel). 2023;11(2):246.) DOI: https://doi.org/10.3390/vaccines11020246

Saldana CS, Kelley CF, Aldred BM, Cantos VD. Mpox and HIV: a Narrative Review. Curr HIV/AIDS Rep. 2023 May 13:1–9. DOI: https://doi.org/10.1007/s11904-023-00661-1

Dar-Odeh N, Abu-Hammad S, Abu-Hammad O. The Emerging Monkeypox Outbreak: A Cause for Concern Among Craniofacial Surgeons. J Craniofac Surg. 2023 Jan-Feb 01;34(1):11. DOI: https://doi.org/10.1097/SCS.0000000000008907

Abu-Hammad, O., Arabiat, D., Althagafi, N., Eshky, R., Abu-Hammad, A., Jaber, A.-R., Jaber, A. R., & Dar-Odeh, N. (2024). Sexually transmitted diseases and HIV co-infection among adult male patients in the 2022 monkeypox outbreak: a systematic review and meta-analysis. Dermatology Reports. https://doi.org/10.4081/dr.2024.9860

Downloads

Download data is not yet available.

Citations